Increase in Infant Measles Deaths during a Nationwide Measles Outbreak-Mongolia, 2015-2016

Journal of Infectious Diseases

Volumn 220, Issue 11, 2019, Pages 1771-1779

  Lee, Christopher T ^a   Hagan, Jose E ^a   Jantsansengee, Baigalmaa ^b   Tumurbaatar, Oyun Erdene ^b   Altanchimeg, Samdan ^c   Yadamsuren, Buyanjargal ^c   Demberelsuren, Sodbayar ^d   Tserendorj, Chinbayar ^c   Munkhtogoo, Oyungerel ^c   Badarch, Darmaa ^c   Gunregjav, Nyamaa ^c   Baatarkhuu, Bolortuya ^e   Ochir, Chimedsuren ^f   Berman, Lashondra ^g   Anderson, Raydel ^g   Patel, Minal K ^a   Gregory, Christopher J ^a   Goodson, James L ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Mongolian Field Epidemiology Training Program   (Mongolia)

^c National Center for Communicable Diseases   (Mongolia)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e National Dermatology Center of Mongolia   (Mongolia)

^f MONGOLIAN NATIONAL UNIVERSITY OF MEDICAL SCIENCES   (Mongolia)

^g NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Case fatality; health care Associated infection; Measles; Mongolia; Mortality

Indexed keywords

ARTICLE; CASE CONTROL STUDY; CHILD; CHILD DEATH; CHILD HOSPITALIZATION; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; EPIDEMIC; FEMALE; HOSPITAL ADMISSION; HUMAN; INFANT; INFECTION RATE; INFLUENZA; MAJOR CLINICAL STUDY; MALE; MEASLES; MEDICAL RECORD; MONGOLIA; MORTALITY RISK; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; HOSPITAL; MORTALITY; NEWBORN; RISK FACTOR; SURVIVAL ANALYSIS;

CASE-CONTROL STUDIES; DISEASE OUTBREAKS; FEMALE; HOSPITALS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MEASLES; MONGOLIA; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 85069884474     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiz140     Document Type: Article

References (32)

1. Rota PA, Moss WJ, Takeda M, de Swart RL, Thompson KM, Goodson JL. Measles. Nat Rev Dis Primers 2016; 2:16049.
2. Thompson KM, Odahowski CL. The costs and valuation of health impacts of measles and rubella risk management policies. Risk Anal 2016; 36:1357-82.
3. Liu L, Oza S, Hogan D, et al. Global, regional, and national causes of under-5 mortality in 2000-15: An updated systematic analysis with implications for the sustainable development goals. Lancet 2016; 388:3027-35.
4. Mahamud A, Burton A, Hassan M, et al. Risk factors for measles mortality among hospitalized Somali refugees displaced by famine, Kenya, 2011. Clin Infect Dis 2013; 57:e160-6.
5. Nandy R, Handzel T, Zaneidou M, et al. Case-fatality rate during a measles outbreak in eastern Niger in 2003. Clin Infect Dis 2006; 42:322-8.
6. Hull HF. Increased measles mortality in households with multiple cases in the Gambia, 1981. Rev Infect Dis 1988; 10:463-7.
7. World Health Organization. Third annual meeting of the Regional Verification Commission for Measles Elimination in the Western Pacific, Seoul, Republic of Korea, 18-24 March 2014. https://iris.wpro.who.int/handle/10665.1/10675. Accessed 3 April 2019.
8. Hagan JE, Takashima Y, Sarankhuu A, et al. Risk factors for measles virus infection among adults during a large outbreak in postelimination era in Mongolia, 2015. J Infect Dis 2017; 216:1187-95.
9. World Health Organization. II. Definitions. Response to measles outbreaks in measles mortality reduction settings: immunization, vaccines and biologicals. Geneva: WHO, 2009: 5-7.
10. Lee CT, Bulterys M, Martel LD, Dahl BA. Evaluation of a national call center and a local alerts system for detection of new cases of Ebola virus disease-Guinea, 2014-2015. MMWR Morb Mortal Wkly Rep 2016; 65:227-30.
11. Bankamp B, Byrd-Leotis LA, Lopareva EN, et al. Improving molecular tools for global surveillance of measles virus. J Clin Virol 2013; 58:176-82.
12. Hummel KB, Lowe L, Bellini WJ, Rota PA. Development of quantitative gene-specific real-Time RT-PCR assays for the detection of measles virus in clinical specimens. J Virol Methods 2006; 132:166-73.
13. World Health Organization. Global database on child growth and malnutrition. http://www.who.int/nutgrowthdb/about/introduction/en/index4.html. Accessed 10 July 2017.
14. Hagan JE, Kriss JL, Takashima Y, et al. Progress toward measles elimination-Western Pacific Region, 2013-2017. MMWR Morb Mortal Wkly Rep 2018; 67:491-5.
15. Kyaw MH, Christie P, Clarke SC, et al. Invasive pneumococcal disease in Scotland, 1999-2001: use of record linkage to explore associations between patients and disease in relation to future vaccination policy. Clin Infect Dis 2003; 37:1283-91.
16. Mahmud SM, Bozat-Emre S, Hammond G, Elliott L, Van Caeseele P. Did the H1N1 vaccine reduce the risk of admission with influenza and pneumonia during the pandemic? PLoS One 2015; 10:e0142754.
17. Orsoo O, Saw YM, Sereenen E, et al. Epidemiological characteristics and trends of a nationwide measles outbreak in Mongolia, 2015-2016. BMC Public Health 2019; 19:201.
18. Botelho-Nevers E, Gautret P, Biellik R, Brouqui P. Nosocomial transmission of measles: An updated review. Vaccine 2012; 30:3996-4001.
19. Maltezou HC, Wicker S. Measles in health-care settings. Am J Infect Control 2013; 41:661-3.
20. Hagan JE, Takahsima Y, Sarankhuu A, et al. Risk factors for measles virus infection among adults during a large outbreak in post-elimination era in Mongolia, 2015. J Infect Dis 2017; 216:1187-95.
21. Chen SY, Anderson S, Kutty PK, et al. Health care-Associated measles outbreak in the United States after an importation: challenges and economic impact. J Infect Dis 2011; 203:1517-25.
22. Strebel PM, Papania M, Gastanaduy PA,Goodson JL. Measles vaccine. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines, 7th ed. Philadelphia, PA: WB Saunders, 2017: 579-618.
23. World Health Organization. Measles vaccines: WHO position paper-April 2017. Wkly Epidemiol Rec 2017; 92:205-28.
24. Hagan JE, Greiner A, Luvsansharav UO, et al. Use of a diagonal approach to health system strengthening and measles elimination after a large nationwide outbreak in Mongolia. Emerg Infect Dis 2017; 23: doi: 10.3201/eid2313.170594.
25. Hai le T, Thach HN, Tuan TA, et al. Adenovirus type 7 pneumonia in children who died from measles-Associated pneumonia, Hanoi, Vietnam, 2014. Emerg Infect Dis 2016; 22:687-90.
26. Mina MJ, Metcalf CJ, de Swart RL, Osterhaus AD, Grenfell BT. Long-Term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science 2015; 348:694-9.
27. Green HN, Mellanby E. Vitamin A as an anti-infective agent. Br Med J 1928; 2:691-6.
28. Imdad A, Mayo-Wilson E, Herzer K, Bhutta ZA. Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age. Cochrane Database Syst Rev 2017; 3:CD008524.
29. Moss WJ. Measles. Lancet 2017; 390:2490-502.
30. World Health Organization. Treating measles in children. http://www.who.int/immunization/programmes-systems/interventions/TreatingMeaslesENG300.pdf. Accessed 13 July 2017.
31. Lander RL, Enkhjargal T, Batjargal J, et al. Multiple micronutrient deficiencies persist during early childhood in Mongolia. Asia Pac J Clin Nutr 2008; 17:429-40.
32. Saraiva BC, Soares MC, Santos LC, Pereira SC, Horta PM. Iron deficiency and anemia are associated with low retinol levels in children aged 1 to 5 years. J Pediatr (Rio J) 2014; 90:593-9.